RecallDepth
Class II Ongoing

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.

This recall is currently active, issued December 17, 2025. It was issued by Cipla Usa, Inc..

Company
Cipla Usa, Inc.
Recall Initiated
October 24, 2025
Posted
December 17, 2025
Recall Number
D-0218-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Warren, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed stability specifications: Out of specification for hardness test

Distribution

Nationwide in the USA

Lot / Code Info

Lot# NB240314, exp 12/31/2025

More recalls by Cipla Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls